{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:21:38Z","timestamp":1792686098760,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,28]],"date-time":"2027-09-28T00:00:00Z","timestamp":1822089600000},"content-version":"am","delay-in-days":392,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jacep.2026.03.026","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T14:29:13Z","timestamp":1774880953000},"page":"2195-2209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Liraglutide Effects in Atrial Fibrillation (LEAF) Study"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9802-1851","authenticated-orcid":false,"given":"Jeffrey J.","family":"Goldberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul D.","family":"Mitrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7702-1913","authenticated-orcid":false,"given":"Ghaith","family":"Zaatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Lowery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Baez-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Blandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry E.","family":"Hurwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex H.","family":"Velasquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Litsa K.","family":"Lambrakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damini","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalda","family":"Zarnegarnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Iacobellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jacep.2026.03.026_bib1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/jama.2024.22451","article-title":"Atrial fibrillation: a review","volume":"333","author":"Ko","year":"2025","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.jacep.2026.03.026_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.124.012939","article-title":"Mechanistic insights from trials of atrial fibrillation ablation: charting a course for the future","volume":"17","author":"Goldberger","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"15","key":"10.1016\/j.jacep.2026.03.026_bib3","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1056\/NEJMoa2502280","article-title":"Pulsed field or cryoballoon ablation for paroxysmal atrial fibrillation","volume":"392","author":"Reichlin","year":"2025","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jacep.2026.03.026_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"January","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.jacep.2026.03.026_bib5","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.jacep.2026.03.026_bib6","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study","volume":"64","author":"Pathak","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.jacep.2026.03.026_bib7","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term Effect of Goal-directed Weight Management in an Atrial Fibrillation Cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jacep.2026.03.026_bib8","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","article-title":"Epicardial adipose tissue in contemporary cardiology","volume":"19","author":"Iacobellis","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacep.2026.03.026_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.932262","article-title":"Epicardial adipose tissue and cardiac arrhythmias: focus on atrial fibrillation","volume":"9","author":"Conte","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"10.1016\/j.jacep.2026.03.026_bib10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/CIRCEP.109.912055","article-title":"Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study","volume":"3","author":"Thanassoulis","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"10.1016\/j.jacep.2026.03.026_bib11","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12872-022-02703-9","article-title":"Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients: a systematic review and meta-analysis","volume":"22","author":"Chen","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"issue":"10","key":"10.1016\/j.jacep.2026.03.026_bib12","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.amjcard.2011.01.027","article-title":"Quantitative analysis of quantity and distribution of epicardial adipose tissue surrounding the left atrium in patients with atrial fibrillation and effect of recurrence after ablation","volume":"107","author":"Tsao","year":"2011","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.jacep.2026.03.026_bib13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.ijcard.2014.08.008","article-title":"Pericardial fat volume is associated with clinical recurrence after catheter ablation for persistent atrial fibrillation, but not paroxysmal atrial fibrillation: an analysis of over 600-patients","volume":"176","author":"Kim","year":"2014","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.jacep.2026.03.026_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074926","article-title":"Epicardial adipose tissue thickness and ablation outcome of atrial fibrillation","volume":"8","author":"Chao","year":"2013","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.jacep.2026.03.026_bib15","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.jacc.2010.11.045","article-title":"Pericardial fat is associated with atrial fibrillation severity and ablation outcome","volume":"57","author":"Wong","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jacep.2026.03.026_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jcct.2015.03.011","article-title":"Periatrial epicardial adipose tissue thickness is an independent predictor of atrial fibrillation recurrence after cryoballoon-based pulmonary vein isolation","volume":"9","author":"Kocyigit","year":"2015","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"3","key":"10.1016\/j.jacep.2026.03.026_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/oby.21718","article-title":"Liraglutide causes large and rapid epicardial fat reduction","volume":"25","author":"Iacobellis","year":"2017","journal-title":"Obesity (Silver Spring)"},{"issue":"16","key":"10.1016\/j.jacep.2026.03.026_bib18","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1161\/CIR.0000000000000748","article-title":"Lifestyle and risk factor modification for reduction of atrial fibrillation: a Scientific Statement from the American Heart Association","volume":"141","author":"Chung","year":"2020","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jacep.2026.03.026_bib19","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.echo.2009.10.013","article-title":"Echocardiographic epicardial fat: a review of research and clinical applications","volume":"22","author":"Iacobellis","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"issue":"9","key":"10.1016\/j.jacep.2026.03.026_bib20","first-page":"587","article-title":"Epicardial fat in atrial fibrillation and heart failure","volume":"46","author":"Iacobellis","year":"2014","journal-title":"Horm Metab Res"},{"issue":"1","key":"10.1016\/j.jacep.2026.03.026_bib21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jacep.2026.03.026_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032277","article-title":"Impact of obesity on atrial fibrillation pathogenesis and treatment options","volume":"13","author":"Sha","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.jacep.2026.03.026_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13499","article-title":"BMI and atrial fibrillation recurrence post catheter ablation: a dose-response meta-analysis","volume":"51","author":"Pranata","year":"2021","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"10.1016\/j.jacep.2026.03.026_bib24","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.hrthm.2017.02.023","article-title":"Impact of obesity on atrial fibrillation ablation: patient characteristics, long-term outcomes, and complications","volume":"14","author":"Winkle","year":"2017","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.jacep.2026.03.026_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/jce.13388","article-title":"Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients","volume":"29","author":"Sivasambu","year":"2018","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"20","key":"10.1016\/j.jacep.2026.03.026_bib26","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012253","article-title":"Impact of body mass index on the outcomes of catheter ablation of atrial fibrillation: a European observational multicenter study","volume":"8","author":"Provid\u00eancia","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.jacep.2026.03.026_bib27","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/jce.15987","article-title":"Impact of obesity on catheter ablation of atrial fibrillation: patient characteristics, procedural complications, outcomes, and quality of life","volume":"34","author":"Tabaja","year":"2023","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"12","key":"10.1016\/j.jacep.2026.03.026_bib28","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1111\/jce.16090","article-title":"The effect of weight loss on recurrence of atrial fibrillation after catheter ablation: a systematic review and meta-analysis","volume":"34","author":"Akhtar","year":"2023","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"10","key":"10.1016\/j.jacep.2026.03.026_bib29","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/europace\/euz183","article-title":"Association between pre-ablation bariatric surgery and atrial fibrillation recurrence in morbidly obese patients undergoing atrial fibrillation ablation","volume":"21","author":"Donnellan","year":"2019","journal-title":"Europace"},{"issue":"10","key":"10.1016\/j.jacep.2026.03.026_bib30","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/europace\/euab122","article-title":"Supervised Obesity Reduction Trial for AF ablation patients: results from the SORT-AF trial","volume":"23","author":"Gessler","year":"2021","journal-title":"Europace"},{"issue":"5","key":"10.1016\/j.jacep.2026.03.026_bib31","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jacep.2020.11.015","article-title":"Atrial fibrillation and obesity: reverse remodeling of atrial substrate with weight reduction","volume":"7","author":"Mahajan","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"issue":"8","key":"10.1016\/j.jacep.2026.03.026_bib32","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.008296","article-title":"Ion channel and structural remodeling in obesity-mediated atrial fibrillation","volume":"13","author":"McCauley","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"10.1016\/j.jacep.2026.03.026_bib33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/cvr\/cvv208","article-title":"Human epicardial adipose tissue has a specific transcriptomic signature depending on its anatomical peri-atrial, peri-ventricular, or peri-coronary location","volume":"108","author":"Gaborit","year":"2015","journal-title":"Cardiovasc Res"},{"issue":"10","key":"10.1016\/j.jacep.2026.03.026_bib34","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.amjcard.2018.08.005","article-title":"Usefulness of epicardial adipose tissue volume to predict recurrent atrial fibrillation after radiofrequency catheter ablation","volume":"122","author":"Maeda","year":"2018","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.jacep.2026.03.026_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.009135","article-title":"Posterior left atrial adipose tissue attenuation assessed by computed tomography and recurrence of atrial fibrillation after catheter ablation","volume":"14","author":"El Mahdiui","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"10","key":"10.1016\/j.jacep.2026.03.026_bib36","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jacc.2020.07.017","article-title":"Epicardial adipose tissue accumulation confers atrial conduction abnormality","volume":"76","author":"Nalliah","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jacep.2026.03.026_bib37","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/europace\/euac031","article-title":"Association between left atrial epicardial fat, left atrial volume, and the severity of atrial fibrillation","volume":"24","author":"van Rosendael","year":"2022","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2026.03.026_bib38","article-title":"Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study","volume":"361","author":"Staerk","year":"2018","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.jacep.2026.03.026_bib39","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4022\/jafib.2051","article-title":"Life's simple 7 approach to atrial fibrillation prevention","volume":"11","author":"Isakadze","year":"2018","journal-title":"J Atr Fibrillation"},{"issue":"8","key":"10.1016\/j.jacep.2026.03.026_bib40","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s00380-018-01327-4","article-title":"Liraglutide suppresses atrial electrophysiological changes","volume":"34","author":"Nakamura","year":"2019","journal-title":"Heart Vessels"},{"issue":"7","key":"10.1016\/j.jacep.2026.03.026_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/clc.24314","article-title":"Glucagon-like peptide-1 receptor agonists and major adverse cardiovascular events in patients with and without diabetes: a meta-analysis of randomized-controlled trials","volume":"47","author":"Hosseinpour","year":"2024","journal-title":"Clin Cardiol"},{"issue":"4","key":"10.1016\/j.jacep.2026.03.026_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/1753-0407.70082","article-title":"Efficacy of GLP-1 receptor agonist-based therapies on cardiovascular events and cardiometabolic parameters in obese individuals without diabetes: a meta-analysis of randomized controlled trials","volume":"17","author":"Yin","year":"2025","journal-title":"J Diabetes"},{"issue":"4","key":"10.1016\/j.jacep.2026.03.026_bib43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.jacep.2026.03.026_bib44","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jacep.2026.03.026_bib45","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa2108269","article-title":"Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes","volume":"385","author":"Gerstein","year":"2021","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.jacep.2026.03.026_bib46","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jacep.2026.03.026_bib47","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1055\/s-0043-109563","article-title":"Human epicardial fat expresses glucagon-like peptide 1 and 2 receptors genes","volume":"49","author":"Iacobellis","year":"2017","journal-title":"Horm Metab Res"},{"issue":"4","key":"10.1016\/j.jacep.2026.03.026_bib48","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1210\/en.2018-00004","article-title":"GLP-1 receptor expression within the human heart","volume":"159","author":"Baggio","year":"2018","journal-title":"Endocrinology"},{"issue":"17","key":"10.1016\/j.jacep.2026.03.026_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713100","article-title":"Glucagon-like peptide-1 receptor activation reduces pulmonary vein arrhythmogenesis and regulates calcium homeostasis","volume":"24","author":"Chan","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacep.2026.03.026_bib50","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwaf257","article-title":"Reduction of new onset of atrial fibrillation in patients treated with semaglutide: an updated systematic review and meta regression analysis of randomized controlled trials","author":"Cesaro","year":"2025","journal-title":"Eur J Prev Cardiol"},{"issue":"8","key":"10.1016\/j.jacep.2026.03.026_bib51","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.jacep.2024.03.031","article-title":"Effects of glucagon-like peptide-1 receptor agonists on atrial fibrillation recurrence after catheter ablation","volume":"10","author":"Satti","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"issue":"8","key":"10.1016\/j.jacep.2026.03.026_bib52","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/jce.16737","article-title":"Long-term impact of GLP-1 receptor agonists on AF recurrence after ablation in obese patients","volume":"36","author":"Patel","year":"2025","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2026.03.026_bib53","first-page":"2","article-title":"TRANSFORM-AF: targeting metabolic therapy with GLP-1 receptor agonism for secondary prevention in atrial fibrillation (abstract)","volume":"22","author":"Selvaganesan","year":"2025","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.jacep.2026.03.026_bib54","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euag018","article-title":"Semaglutide as adjunctive therapy to catheter ablation in obesity-related paroxysmal atrial fibrillation","volume":"28","author":"Ciconte","year":"2026","journal-title":"Europace"},{"issue":"10516","key":"10.1016\/j.jacep.2026.03.026_bib55","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/S0140-6736(25)01375-3","article-title":"Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial","volume":"406","author":"Deanfield","year":"2025","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jacep.2026.03.026_bib56","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.jacc.2024.08.088","article-title":"How semaglutide effects on epicardial fat inflammation can be good for the heart","volume":"85","author":"Iacobellis","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jacep.2026.03.026_bib57","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.RES.0000163635.62927.34","article-title":"Adipose tissue, inflammation, and cardiovascular disease","volume":"96","author":"Berg","year":"2005","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.jacep.2026.03.026_bib58","first-page":"6550","article-title":"The integrative network of circRNA, miRNA and mRNA of epicardial adipose tissue in patients with atrial fibrillation","volume":"14","author":"Zheng","year":"2022","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jacep.2026.03.026_bib59","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fcvm.2019.00115","article-title":"Micro-RNAs are related to epicardial adipose tissue in participants with atrial fibrillation: data from the MiRhythm study","volume":"6","author":"Tran","year":"2019","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.jacep.2026.03.026_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.numecd.2024.08.019","article-title":"Liraglutide effects on epicardial adipose tissue micro-RNAs and intra-operative glucose control","volume":"35","author":"Iacobellis","year":"2025","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"9","key":"10.1016\/j.jacep.2026.03.026_bib61","article-title":"Semaglutide modulates proinflammatory epicardial adipogenesis with paracrine effects on hiPSC-atrial cardiomyocytes","volume":"10","author":"Basdas","year":"2025","journal-title":"JACC Basic Transl Sci"},{"issue":"9","key":"10.1016\/j.jacep.2026.03.026_bib62","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jacc.2024.05.065","article-title":"Effect of semaglutide on epicardial adipose tissue in type 2 diabetes: insights from the STOP (Semaglutide Treatment effect On coronary atherosclerosis Progression) randomized trial","volume":"84","author":"Manubolu","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"10151","key":"10.1016\/j.jacep.2026.03.026_bib63","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(18)31114-0","article-title":"Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study):a post-hoc analysis of prospective outcome data","volume":"392","author":"Oikonomou","year":"2018","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.jacep.2026.03.026_bib64","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1161\/CIRCULATIONAHA.119.042287","article-title":"Aerobic exercise induces cardiac fat loss and alters cardiac muscle mass through an interleukin-6 receptor-dependent mechanism: cardiac analysis of a double-blind randomized controlled clinical trial in abdominally obese humans","volume":"140","author":"Christensen","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jacep.2026.03.026_bib65","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.2025.21056","article-title":"Caffeinated coffee consumption or abstinence to reduce atrial fibrillation: the DECAF randomized clinical trial","volume":"335","author":"Wong","year":"2026","journal-title":"JAMA"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X26002707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X26002707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:12:37Z","timestamp":1790896357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X26002707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":65,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2405500X26002707"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2026.03.026","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Liraglutide Effects in Atrial Fibrillation (LEAF) Study","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2026.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}